Anastomotic bilio-biliary stricture after adult liver transplantation: A retrospective study over 20 years in a single center

Jérôme Dumortier, Christine Chambon-Augoyard, Olivier Guillaud, Mathieu Pioche, Jérôme Rivory, Pierre Jean Valette, Mustapha Adham, Thierry Ponchon, Jean Yves Scoazec, Olivier Boillot

Résultats de recherche: Contribution à un journalArticleRevue par des pairs

8 Citations (Scopus)

Résumé

Background: Biliary complications are the main surgical complication after liver transplantation (LT). The aims of the present retrospective single center study were to describe anastomotic bilio-biliary strictures (ABS) in a large cohort of liver transplant recipients with long follow-up. Methods: All adult LT recipients who underwent a LT, with bilio-biliary anastomosis, between 1990 and 2010 in Edouard Herriot hospital, Lyon, France were included in the study. Results: The study population consisted in 783 patients (70.0% males), median age 50.5 years; main indication was alcohol-related liver disease (46.8%). The median follow-up after LT was 11.9 years (range 0–27 years). The overall incidence of anastomotic biliary complications was 9.7%: 50 patients developed an ABS (6.6%), after a median delay of 4.4 months (range 0.1–245.2) after LT and 32 (4.1%) developed biliary leakage after a median delay of 25 days (range 1–179). The actuarial risk of developing an ABS was 1.6% at 1-month, 2.7% at 3-months, 4.1% at 6-months, and 5.1%, 6.0%, 6.4%, 6.6%, 7.3% at 1-, 2-, 5-, 10- and 15-years, respectively. Univariate analysis disclosed that post-reperfusion syndrome and liver graft steatosis (≥ 30%) were significant risk factors for ABS. Multivariate analysis disclosed that graft steatosis (OR = 6.262, 95%CI 1.936–20.257, P = 0.002) and MELD score (OR = 1.071, 95%CI 1.018–1.128, P = 0.008) were significant risk factors for ABS. The first-line treatment of ABS consisted in endoscopic stenting for 44 patients (88.0%) and immediate success rate was 75.0%. Delayed recurrence of ABS occurred in 8/33 patients (24.0%). Conclusion: Our results suggest that steatotic grafts should be used for recipients without severe liver failure to avoid ABS, and that endoscopic stenting of post-LT ABS leads to a high success rate, but is associated with a significant risk of recurrence.

langue originaleAnglais
Pages (de - à)564-571
Nombre de pages8
journalClinics and Research in Hepatology and Gastroenterology
Volume44
Numéro de publication4
Les DOIs
étatPublié - 1 sept. 2020
Modification externeOui

Contient cette citation